Circadian Clock Controls Sugar Metabolism

The body’s circadian rhythm has more of an effect on glucose tolerance than one’s eating and sleeping patterns, a study shows.


Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, JACOB TOORNVLIET's 'THE SLEEPING WOMAN' Humans’ 24-hour circadian clock plays a leading role in glucose tolerance, according to a study published today (April 13) in PNAS. Researchers in Boston have found that, because of body’s circadian rhythm, human glucose tolerance is reduced during the evening hours, even when “day” and “night” times are experimentally reversed.

“In a prior [human] study, we found that when behavior cycles of feeding and sleeping are not in normal alignment with the internal body clock, that this negatively affects the regulation of blood sugar and especially glucose tolerance,” said neuroscientist Frank Scheer from the Division of Sleep and Circadian Disorders at the Brigham and Women’s Hospital in Boston. People who work night shifts are more prone to type 2 diabetes and obesity, he noted.

In an attempt to understand the independent effects of eating and sleeping behaviors versus the circadian clock on glucose tolerance, Scheer and his colleagues mimicked night-shift work in 14 healthy individuals under controlled laboratory conditions. Participants spent eight days on a typical day-shift schedule, eating breakfast at 8:00 in the morning, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio